FDA questions on genAI-enabled chatbots raise concerns from expert panel
Regulatory NewsJeff Craven
Advisory committeesArtificial intelligence/machine learning (AI/ML)CDRHDigital health/SaMD/AIMedical DevicesProduct LifecycleUnited StatesRegulatory NewsJeff CravenAdvisory committeesArtificial intelligence/machine learning (AI/ML)CDRHDigital health/SaMD/AIMedical DevicesProduct LifecycleUnited States